Tumor Analyses Reveal Squamous Transformation and Off-Target Alterations As Early Resistance Mechanisms to First-line Osimertinib in <i>EGFR</i> -Mutant Lung CancerAdam J. Schoenfeld, Helena A. Yu, Daisuke Kubota et al.|Clinical Cancer Research|2020Cited by 381
Targeting the miR-200c/LIN28B axis in acquired EGFR-TKI resistance non-small cell lung cancer cells harboring EMT featuresHiroki Sato, Shinichi Toyooka|Scientific Reports|2017Cited by 60
Therapeutic potential of targeting S100A11 in malignant pleural mesotheliomaHiroki Sato, Shinichi Toyooka|Oncogenesis|2018Cited by 27
Allele-Specific Role of ERBB2 in the Oncogenic Function of EGFR L861Q in EGFR-Mutant Lung CancersHiroki Sato, Marc Ladanyi|Journal of Thoracic Oncology|2020Cited by 19